Sun Pharma’s ILUMYA Shows Promise in Psoriatic Arthritis Trials, Eyeing U.S. Market
Sun Pharmaceutical Industries Ltd has announced promising results from clinical trials of its psoriasis drug ILUMYA, potentially paving the way for regulatory filings in the US and marking a significant milestone in the treatment of psoriatic arthri…
- Sun Pharmaceutical Industries Ltd
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
3 minutes to read